After a relatively quiet Monday, this morning brought a fresh batch of big-name second-quarter earnings reports.
By Ian Wyatt | May 1, 2012
Pharmaceutical giant Pfizer (NYSE: PFE) reported slow earnings growth last quarter after losing a patent on its Lipitor drug.
By Ian Wyatt | Jan 31, 2012
Exxon Mobil (NYSE: XOM) and UPS (NYSE: UPS) were among the companies that reported mixed earnings results on Tuesday.
By Ian Wyatt | Nov 29, 2011
Wednesday is the dawn of a new era for Pfizer Inc. (NYSE: PFE), as it will give rise to some serious competition for the pharmaceutical giant’s wildly successful heart drug Lipitor.